The skin, our largest organ, is constantly under surveillance by immune cells that defend against a host of potential threats, from bacteria to viruses. Now, researchers have pinpointed a genetic defect that can cripple this defense, leaving individuals vulnerable to unchecked viral growth and an increased risk of skin cancer. This discovery sheds fresh light on the complex interplay between genetics, immunity, and viral infection, particularly in the rare condition known as epidermodysplasia verruciformis (EV). Understanding the genetic basis of EV is crucial for developing targeted therapies and improving outcomes for those affected by this challenging disease.
For healthy individuals, the immune system efficiently clears commensal human papillomaviruses (HPVs) – viruses commonly found on the skin – from infected cells. However, in people with EV, these typically harmless HPVs persist, leading to the development of warts and a significantly elevated risk of non-melanoma skin cancer. Scientists have long suspected a link between T cell immunity and EV, prompting a deeper investigation into the genetic factors at play. A recent study, published in Science Immunology, has revealed a key piece of the puzzle: variations in the ITGAL gene.
Unraveling the Genetic Link to Impaired Immunity
Researchers at The Rockefeller University and collaborating institutions examined 62 unrelated patients with EV. While 22 were found to carry previously known genetic variants associated with the condition, the genetic basis remained elusive for the remaining individuals. Further investigation revealed that several of these patients carried inherited variants in the ITGAL gene. This gene provides instructions for making a protein called the αL integrin chain, which, when paired with another protein, forms lymphocyte function-associated antigen-1 (LFA-1). LFA-1 is broadly expressed on leukocytes, including T cells, and plays a critical role in immune cell migration.
The team discovered that the mutant αL proteins resulting from these ITGAL variants led to a loss of LFA-1 expression on the surface of T cells. This deficiency had a direct impact on the cells’ ability to move. In laboratory tests, cells carrying the ITGAL mutations failed to migrate effectively toward a chemokine – a signaling molecule that attracts immune cells to sites of infection or inflammation – while cells with normal ITGAL genes exhibited robust movement. Leukocytes from affected patients also showed markedly reduced LFA-1 expression and impaired migratory capacity, confirming the findings.
How Defective T Cell Migration Impacts Skin Defense
Skin memory T cells are essential for ongoing skin defense, constantly circulating between the bloodstream and the skin to monitor for threats. The study revealed that while LFA-1-deficient memory T cells developed and differentiated normally, they were unable to effectively migrate into the skin. Instead, these crucial immune cells accumulated in the bloodstream, unable to reach the site where they were needed most. This impaired migration allows commensal HPVs to proliferate unchecked, leading to the characteristic lesions and increased cancer risk seen in EV.
“This discovery could completely change how we think about the development of cutaneous squamous cell carcinoma (cSCC) in people who have an underlying immune defect,” said Andrea Lisco, M.D., Ph.D., of NIH’s National Institute of Allergy and Infectious Diseases (NIAID), in a news release. “It suggests that there may be more people out there with aggressive forms of cSCC who have an underlying immune defect and could benefit from treatments targeting the immune system.”
Beyond EV: Implications for Immunocompromised Individuals
The findings have broader implications beyond EV. Researchers at the National Institutes of Health (NIH) recently demonstrated that beta-HPV, a type of human papillomavirus commonly found on the skin, can directly cause cutaneous squamous cell carcinoma (cSCC) in individuals with compromised immune systems. This July 30, 2025, NIH study, published in The New England Journal of Medicine, challenges the previous understanding that HPV merely facilitated DNA mutations caused by ultraviolet (UV) radiation.
The identification of ITGAL variants as contributors to the genetic basis of EV opens avenues for potential therapeutic interventions. Further research is needed to explore strategies to restore LFA-1 expression or enhance T cell migration in affected individuals. The discovery also highlights the importance of considering genetic factors in individuals presenting with unusual or aggressive skin lesions, particularly those with a history of immune dysfunction.
Looking ahead, researchers plan to investigate the prevalence of ITGAL variants in larger cohorts of EV patients and explore the potential for gene therapy or other targeted approaches to restore immune function. The ongoing function promises to refine our understanding of the complex relationship between genetics, immunity, and viral infection, ultimately leading to improved prevention and treatment strategies for individuals at risk.
This research underscores the importance of continued investigation into the genetic underpinnings of immune disorders and their impact on susceptibility to viral infections and cancer. If you have concerns about skin lesions or a family history of EV, consult with a qualified healthcare professional.
Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare professional for diagnosis and treatment of any medical condition.
What are your thoughts on this new research? Share your comments below, and please share this article with anyone who might find it helpful.
